Pharmacoproteogenomic approach identifies on-target kinase inhibitors for cancer drug repositioning
{{output}}
Drug repositioning of approved drugs offers advantages over de novo drug development for a rare type of cancer. To efficiently identify on-target drugs from clinically successful kinase inhibitors in cancer drug repositioning, drug screening and molecular prof... ...
